Yunkun Lu

463 total citations
19 papers, 249 citations indexed

About

Yunkun Lu is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Yunkun Lu has authored 19 papers receiving a total of 249 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Cancer Research and 3 papers in Surgery. Recurrent topics in Yunkun Lu's work include MicroRNA in disease regulation (4 papers), RNA modifications and cancer (4 papers) and Epigenetics and DNA Methylation (3 papers). Yunkun Lu is often cited by papers focused on MicroRNA in disease regulation (4 papers), RNA modifications and cancer (4 papers) and Epigenetics and DNA Methylation (3 papers). Yunkun Lu collaborates with scholars based in China, Canada and United States. Yunkun Lu's co-authors include Chang Bao, Danni Chen, Weimin Fan, Bisha Ding, Liang Xu, Weiyang Lou, Weiyang Lou, Ziyu Zhou, Xiaojie Ma and Yan Jin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Scientific Reports.

In The Last Decade

Yunkun Lu

16 papers receiving 245 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yunkun Lu China 8 183 98 34 25 23 19 249
France‐Hélène Joncas Canada 7 201 1.1× 69 0.7× 30 0.9× 35 1.4× 28 1.2× 15 286
Yibei Dai China 10 223 1.2× 107 1.1× 19 0.6× 24 1.0× 35 1.5× 21 339
Jinduan Lin China 10 194 1.1× 160 1.6× 19 0.6× 36 1.4× 25 1.1× 23 325
Ziqin Liu China 9 192 1.0× 89 0.9× 12 0.4× 46 1.8× 37 1.6× 26 275
Yu Lv China 9 236 1.3× 167 1.7× 12 0.4× 29 1.2× 17 0.7× 16 306
Francesca Maria Orlandella Italy 13 188 1.0× 141 1.4× 16 0.5× 51 2.0× 29 1.3× 26 317
Meng‐Lay Lin United Kingdom 6 209 1.1× 60 0.6× 12 0.4× 56 2.2× 30 1.3× 6 268
Julie‐Ann Cavallo United States 3 121 0.7× 43 0.4× 17 0.5× 49 2.0× 18 0.8× 3 195
Yutong Chen China 10 159 0.9× 85 0.9× 11 0.3× 33 1.3× 24 1.0× 23 228
Xuetian Zhang China 8 242 1.3× 86 0.9× 17 0.5× 66 2.6× 33 1.4× 10 322

Countries citing papers authored by Yunkun Lu

Since Specialization
Citations

This map shows the geographic impact of Yunkun Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunkun Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunkun Lu more than expected).

Fields of papers citing papers by Yunkun Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yunkun Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunkun Lu. The network helps show where Yunkun Lu may publish in the future.

Co-authorship network of co-authors of Yunkun Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Yunkun Lu. A scholar is included among the top collaborators of Yunkun Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yunkun Lu. Yunkun Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Wang, Qianqian, Ke Guo, Yunkun Lu, et al.. (2025). CD47 blockade reverses resistance to HDAC inhibitor by liberating anti-tumor capacity of macrophages. Journal of Experimental & Clinical Cancer Research. 44(1). 67–67. 9 indexed citations
2.
Xiao, Peng, Zhehang Chen, Wenhao Xia, et al.. (2025). Targeting hyaluronan synthesis enhances the therapeutic effectiveness of biologics in inflammatory bowel disease. JCI Insight. 10(1).
3.
Xie, Jinyan, et al.. (2025). Akkermansia Muciniphila Alleviates Severe Acute Pancreatitis via Amuc1409‐Ube2k‐Foxp3 Axis in Regulatory T Cells. Advanced Science. 12(30). e04214–e04214. 1 indexed citations
4.
Lu, Yunkun, et al.. (2025). Deciphering alternative splicing patterns during cell fate transition of fast chemical reprogramming. BMC Biology. 23(1). 164–164. 1 indexed citations
5.
Wang, Weiyun, Yunkun Lu, Jie Xu, et al.. (2025). Skatole Alleviates Osteoarthritis by Reprogramming Macrophage Polarization and Protecting Chondrocytes. Research. 8. 604–604. 4 indexed citations
6.
Huang, Yuliang, Yunkun Lu, Qiang Sun, et al.. (2024). The phase separation of extracellular matrix protein matrilin‐3 from cancer‐associated fibroblasts contributes to gastric cancer invasion. The FASEB Journal. 38(2). e23406–e23406. 7 indexed citations
7.
Lu, Yunkun, et al.. (2024). ACLS4 could be a potential therapeutic target for severe acute pancreatitis. Scientific Reports. 14(1). 13457–13457. 2 indexed citations
8.
Lu, Yunkun, Jie Cao, Ziyu Zhou, et al.. (2024). N -acetyltransferase NAT10 controls cell fates via connecting mRNA cytidine acetylation to chromatin signaling. Science Advances. 10(2). eadh9871–eadh9871. 27 indexed citations
10.
Jin, Yan, Yunkun Lu, Lian‐Yu Lin, et al.. (2023). Harnessing endogenous transcription factors directly by small molecules for chemically induced pluripotency inception. Proceedings of the National Academy of Sciences. 120(21). e2215155120–e2215155120. 5 indexed citations
11.
Yuan, Shuai, Baohua Hou, Zhiqiang Liu, et al.. (2023). CEP20 promotes invasion and metastasis of non-small cell lung cancer cells by depolymerizing microtubules. Scientific Reports. 13(1). 17484–17484. 1 indexed citations
12.
13.
Ma, Xiaojie, Yunkun Lu, Ziyu Zhou, et al.. (2022). Human expandable pancreatic progenitor–derived β cells ameliorate diabetes. Science Advances. 8(8). eabk1826–eabk1826. 34 indexed citations
14.
Ma, Xiaojie, Jie Cao, Ziyu Zhou, et al.. (2022). N6-methyladenosine modification-mediated mRNA metabolism is essential for human pancreatic lineage specification and islet organogenesis. Nature Communications. 13(1). 4148–4148. 14 indexed citations
15.
Lu, Yunkun, Lisha Sun, Shuangying Hao, et al.. (2022). MiR-95-3p acts as a prognostic marker and promotes cervical cancer progression by targeting VCAM1. Annals of Translational Medicine. 10(21). 1171–1171. 7 indexed citations
16.
Bao, Chang, Danni Chen, Yunkun Lu, et al.. (2020). MiR-93 suppresses tumorigenesis and enhances chemosensitivity of breast cancer via dual targeting E2F1 and CCND1. Cell Death and Disease. 11(8). 618–618. 44 indexed citations
17.
He, Jiamin, Qiwei Ge, Weiyi Shen, et al.. (2020). MiR‐129‐5p induces cell cycle arrest through modulating HOXC10/Cyclin D1 to inhibit gastric cancer progression. The FASEB Journal. 34(6). 8544–8557. 23 indexed citations
18.
Xu, Xiaoyang, Jun Zhang, Min Liu, et al.. (2019). NudC-like protein 2 restrains centriole amplification by stabilizing HERC2. Cell Death and Disease. 10(9). 628–628. 9 indexed citations
19.
Bao, Chang, Yunkun Lu, Danni Chen, et al.. (2019). Exploring specific prognostic biomarkers in triple-negative breast cancer. Cell Death and Disease. 10(11). 807–807. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026